To identify factors associated with Opioid Agonist Treatment
(OAT) satisfaction and to determine whether these relationships are gender
specific.
This study was based on data collected in a cross-sectional
study among long-term opioid-dependent individuals (n = 160; 46.3% women).
Participants completed the Client Satisfaction Questionnaire in reference to
OAT episodes. Sociodemographic, illicit substance use, health, and addiction
treatment history data were collected. Multivariable linear regression was used
to determine the relationship between these variables and treatment
satisfaction. To explore the potential role of gender in these identified
relationships stratified multivariable models were tested. Additional
open-ended questions regarding positive and negative perceptions of treatment
were collected, and a thematic analysis was conducted.
In the multivariable linear regression model, participants
who were older, of Aboriginal ancestry, and currently receiving OAT had higher
OAT satisfaction scores, whereas participants who had methadone dose
preferences of 30 mg or less had lower OAT satisfaction. In stratified analyses
among women, the relationship between preferred methadone dose and current OAT
remained significantly associated with satisfaction. Open-ended positive and
negative perceptions complemented and provided further valuable data to
interpret these identified relationships.
To our knowledge, this is the first study to explore the
potential role of gender in factors associated with OAT satisfaction. These
findings provide valuable information to health care providers working in OAT
settings regarding how to address women and men's OAT needs and improve
treatment satisfaction.
Full article
at: http://goo.gl/uCdxJf
By: Kirsten Marchand, BSc, Heather Palis, BA, Defen Peng, PhD, Jill Fikowski, BA, Scott Harrison, MA, Patricia Spittal, PhD, Martin T. Schechter, PhD, MD, and Eugenia Oviedo-Joekes, PhD
Centre for Health
Evaluation & Outcome Sciences (KM, HP, DP, JF, PS, MTS, EOJ), Providence
Health Care, St Paul's Hospital, Vancouver, BC, Canada; and School of
Population and Public Health (KM, HP, JF, PS, MTS, EOJ) and School of Nursing
(SH), University of British Columbia, Vancouver, BC, Canada.
Send correspondence and reprint requests to Dr Eugenia
Oviedo-Joekes, PhD, Centre for Health Evaluation & Outcome Sciences,
Providence Health Care, St Paul's Hospital, 575--1081 Burrard St, Vancouver, BC
V6Z 1Y6, Canada. E-mail: ac.cbu.soehc@ainegue.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment